Sources of inaccuracy in photoplethysmography for continuous cardiovascular monitoring

Photoplethysmography (PPG) is a low-cost, noninvasive optical technique that uses change in light transmission with changes in blood volume within tissue to provide information for cardiovascular health and fitness. As remote health and wearable medical devices become more prevalent, PPG devices are being developed as part of wearable systems to monitor parameters such as heart rate (HR) that do not require complex analysis of the PPG waveform. However, complex analyses of the PPG waveform yield valuable clinical information, such as: blood pressure, respiratory information, sympathetic nervous system activity, and heart rate variability. Systems aiming to derive such complex parameters do not always account for realistic sources of noise, as testing is performed within controlled parameter spaces. A wearable monitoring tool to be used beyond fitness and heart rate must account for noise sources originating from individual patient variations (e.g., skin tone, obesity, age, and gender), physiology (e.g., respiration, venous pulsation, body site of measurement, and body temperature), and external perturbations of the device itself (e.g., motion artifact, ambient light, and applied pressure to the skin). Here, we present a comprehensive review of the literature that aims to summarize these noise sources for future PPG device development for use in health monitoring

Long-term monitoring of respiratory metrics using wearable devices

Recently, there has been an increased interest in monitoring health using wearable sensors technologies however, few have focused on breathing. The utility of constant monitoring of breathing is currently not well understood, both for general health as well as respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) that have significant prevalence in society. Having a wearable device that could measure respiratory metrics continuously and non-invasively with high adherence would allow us to investigate the significance of ambulatory breathing monitoring in health and disease management. The purpose of this thesis was to determine if it was feasible to continuously monitor respiratory metrics. To do this, we identified pulse oximetry to provide the best balance between use of mature signal processing methods, commercial availability, power efficiency, monitoring site and perceived wearability. Through a survey, it was found users would monitor their breathing, irrespective of their health status using a smart watch. Then it was found that reducing the duty cycle and power consumption adversely affected the reliability to capture accurate respiratory rate measurements through pulse oximetry. To account for the decreased accuracy of PPG derived respiratory rate at higher rates, a long short-term memory (LSTM) network and a U-Net were proposed, characterised and implemented. In addition to respiratory rate, inspiration time, expiration time, inter-breath intervals and the Inspiration:Expiration ratio were also predicted. Finally, the accuracy of these predictions was validated using pilot data from 11 healthy participants and 11 asthma participants. While percentage bias was low, the 95\% limits of agreement was high. While there is likely going to be enthusiastic uptake in wearable device use, it remains unseen whether clinical utility can be achieved, in particular the ability to forecast respiratory status. Further, the issues of sensor noise and algorithm performance during activity was not calculated. However, this body of work has investigated and developed the use of pulse oximetry, classical signal processing and machine learning methodologies to extract respiratory metrics to lay a foundation for both the hardware and software requirements in future clinical research

Wearable and Nearable Biosensors and Systems for Healthcare

Biosensors and systems in the form of wearables and “nearables” (i.e., everyday sensorized objects with transmitting capabilities such as smartphones) are rapidly evolving for use in healthcare. Unlike conventional approaches, these technologies can enable seamless or on-demand physiological monitoring, anytime and anywhere. Such monitoring can help transform healthcare from the current reactive, one-size-fits-all, hospital-centered approach into a future proactive, personalized, decentralized structure. Wearable and nearable biosensors and systems have been made possible through integrated innovations in sensor design, electronics, data transmission, power management, and signal processing. Although much progress has been made in this field, many open challenges for the scientific community remain, especially for those applications requiring high accuracy. This book contains the 12 papers that constituted a recent Special Issue of Sensors sharing the same title. The aim of the initiative was to provide a collection of state-of-the-art investigations on wearables and nearables, in order to stimulate technological advances and the use of the technology to benefit healthcare. The topics covered by the book offer both depth and breadth pertaining to wearable and nearable technology. They include new biosensors and data transmission techniques, studies on accelerometers, signal processing, and cardiovascular monitoring, clinical applications, and validation of commercial devices

The design and evaluation of discrete wearable medical devices for vital signs monitoring

The observation, recording and appraisal of an individual’s vital signs, namely temperature, heart rate, blood pressure, respiratory rate and blood oxygen saturation (SpO2), are key components in the assessment of their health and wellbeing. Measurements provide valuable diagnostic data, facilitating clinical diagnosis, management and monitoring. Respiratory rate sensing is perhaps the most under-utilised of all the vital signs, being routinely assessed by observation or estimated algorithmically from respiratory-induced beat-to-beat variation in heart rate. Moreover there is an unmet need for wearable devices that can measure all or most of the vital signs. This project therefore aims to a) develop a device that can measure respiratory rate and b) develop a wearable device that can measure all or most of the vital signs. An accelerometer-based clavicular respiratory motion sensor was developed and compared with a similar thoracic motion sensor and reference using exhalatory flow. Pilot study results established that the clavicle sensor accurately tracked the reference in monitoring respiratory rate and outperformed the thoracic device. An Ear-worn Patient Monitoring System (EPMS) was also developed, providing a discrete telemonitoring device capable of rapidly measuring tympanic temperature, heart rate, SpO2 and activity level. The results of a comparative pilot study against reference instruments revealed that heart rate matched the reference for accuracy, while temperature under read (< 1°C) and SpO2 was inconsistent with poor correlation. In conclusion, both of the prototype devices require further development. The respiratory sensor would benefit from product engineering and larger scale testing to fully exploit the technology, but could find use in both hospital and community-based The design and evaluation of discrete wearable medical devices for vital signs monitoring DG Pitts ii Cranfield University monitoring. The EPMS has potential for clinical and community use, having demonstrated its capability of rapidly capturing and wirelessly transmitting vital signs readings. Further development is nevertheless required to improve the thermometer probe and resolve outstanding issues with SpO2 readings

Development and Testing of an Implantable Perfusion and Oxygenation Sensor for Liver Transplant Monitoring

Since the first successful liver transplant in 1968 the surgery has become very common and 6,291 patients received liver transplants in 2010 in the United States. However, the monitoring methods used post-surgery, in the recovery phase, are still very basic and rely mainly on blood tests and looking for unusual symptoms. Complications are usually detected after the organ is substantially damaged which poses a risk to the patients’ life. This dissertation presents the development and testing of an implantable sensor that can potentially be used to monitor the transplant continuously and transmit the information wirelessly to the medical staff for timely intervention. Such a sensor could have a great effect on survival and reduction of retransplantation rates. The presented sensor employs near infrared spectroscopy to measure perfusion changes, arterial oxygenation and venous oxygenation in the parenchyma of the liver tissue and the supplying vessels. Light at three different wavelengths (735-, 805- and 940-nm) is shined on the tissue and the diffuse reflectance is collected via a photodetector. The collected signals can be transmitted wirelessly to an external unit for processing and display. In this dissertation, different perfusion and oxygenation monitoring techniques are reviewed and the instrumentation of an NIRS based wireless sensor is introduced. A phantom that mimics the anatomy of the liver and its optical and mechanical properties is presented. The processing methods to extract the information of interest from the diffuse reflectance are described in details. Finally, results from in vitro phantom experiments, ex vivo perfused livers and in vivo porcine studies are presented. The first in vivo wireless monitoring of hepatic perfusion and oxygenation levels is reported. The studies show that the sensor can track perfusion changes with a resolution of 0.1 mL/min/g of tissue. The possibility of tracking oxygen saturation changes is also shown as well as the ability to separate them from perfusion changes. Combining results from the pulsatile wave and DC levels, venous and arterial oxygen saturation changes were tracked with a resolution of 1.39% and 2.19% respectively. In conclusion, optical spectroscopy is shown to track perfusion, and arterial and venous oxygenation in tissue. In particular, the method was tested on hepatic and intestinal tissue